Yalcin, Ahmet Igir <br/><br/>
Effect of spironolactone on impaired fibrinolysis of hypertensive patients.  [electronic resource] 

 -  Kidney & blood pressure research  2002 
 - 260-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1420-4096 
<br/><br/><label>Standard No.: </label>10.1159/000066348  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aldosterone--metabolism<br/>Female<br/>Fibrinolysis--drug effects<br/>Humans<br/>Hypertension--drug therapy<br/>Male<br/>Middle Aged<br/>Mineralocorticoid Receptor Antagonists--therapeutic use<br/>Plasminogen Activator Inhibitor 1--metabolism<br/>Spironolactone--therapeutic use<br/>Tissue Plasminogen Activator--metabolism